GlaxoSmithKline plc (GSK)

Introduction
GlaxoSmithKline (GSK) is a global biopharmaceutical company headquartered in London, UK. Established in 2000 through the merger of Glaxo Wellcome and SmithKline Beecham, GSK focuses on the research, development, and commercialization of innovative medicines and vaccines. With over a century of legacy brands behind its name, GSK is one of the largest healthcare companies in the world.

Mission and Vision

Mission: To unite science, technology, and talent to get ahead of disease together.
Vision: To positively impact the health of billions of people while delivering sustainable growth and shareholder value.

Products and Services

Pharmaceuticals: Treatments for HIV, oncology, respiratory diseases, and immune disorders.
Vaccines: One of the largest vaccine portfolios globally, including vaccines for meningitis, shingles, and influenza.
Consumer Healthcare (until 2022): Previously a leader in OTC medicines, oral care, and wellness products (now spun off into Haleon).
Specialty Medicines: Innovative therapies in areas like oncology, immunology, and infectious diseases.

Growth and Innovation
GSK has restructured to focus more heavily on biopharma and vaccines, with significant investments in R&D, including cutting-edge work in mRNA technologies, immunotherapies, and AI-driven drug discovery. The spin-off of its consumer healthcare division into Haleon in 2022 allowed GSK to concentrate fully on high-value pharmaceuticals and vaccines.

Global Impact
Operating in more than 100 countries, GSK plays a vital role in public health through its vaccines and HIV treatments. The company is a long-time partner of global health organizations like GAVI and the World Health Organization, working to expand vaccine access in developing nations. GSK has also committed to ambitious sustainability goals, including achieving net zero impact on climate and nature by 2030.